Uterine-sparing interventions for symptomatic adenomyosis: Rates of recurrence and reintervention

	Recurrence rates (%)	Reintervention rates (%)	Comments
Uterine artery embolization	29.5	12.8	16 studies (816 patients)
Adenomyomectomy	12.6	2.6	14 studies (1792 patients) Other interventions (eg, GnRH agonist, LNG IUD) were also used in some patients
Thermal ablation	10	8.2	12 studies (3271 patients) Includes HIFU and RFA

Results from a meta-analysis of observational studies including patients with adenomyosis undergoing uterine-sparing procedures; follow-up ranged from six months to seven years.

GnRH: gonadotropin-releasing hormone; HIFU: high-intensity focused ultrasound; LNG IUD: levonorgestrel releasing intrauterine device; RFA: radiofrequency ablation.

Data from: Liu L, Tian H, Lin D, et al. Risk of Recurrence and Reintervention After Uterine-Sparing Interventions for Symptomatic Adenomyosis: A Systematic Review and Meta-Analysis. Obstet Gynecol 2023; 141:711.

Graphic 142983 Version 1.0

خرید پکیج

Uterine-sparing interventions for symptomatic adenomyosis: Rates of recurrence and reintervention